Skip to main content

Table 1 Correlation between NPL4 mRNA expression and clinicopathological characteristics

From: Upregulation of NPL4 promotes bladder cancer cell proliferation by inhibiting DXO destabilization of cyclin D1 mRNA

Characteristics Number of patients (%) NPL4 expression P valuea
Low (%) High (%)
Total no. of patients 35 18 17  
Age (years)
 ≤ 63b 17 9 (52.94) 8 (47.06) 1.000
 > 63 18 9 (50.00) 9 (50.00)
Gender
 Male 22 12 (54.55) 10 (45.45) 0.733
 Female 13 6 (46.15) 7 (53.85)
Tumor size (cm)
 ≤ 3.0c 22 14 (63.64) 8 (36.36) 0.035
 > 3.0 13 3 (23.08) 10 (76.92)
Tumor grade
 Low 21 10 (45.45) 11 (54.55) 0.733
 High 14 8 (57.14) 6 (42.86)
T classification
 Ta, T1 23 13 (56.52) 10 (43.48) 0.489
 T2–T4 12 5 (41.67) 7 (58.33)
pN status
 pN− 27 13 (48.15) 14 (51.85) 0.691
 pN+ 8 5 (62.50) 3 (37.50)
Tumor multiplicity
 Unifocal 15 11 (41.67) 4 (41.67) 0.041
 Multifocal 20 7 (41.67) 13 (41.67)
  1. Significant associations are shown in italic face in the P value column (P value < 0.05)
  2. aChi square test
  3. bMedian age
  4. cMedian size